Young BJP candidate Tejasvi Surya accused of abusing, beating women

News Network
March 28, 2019

Bengaluru, Mar 28: Bharatiya Janata Party candidate from Bengaluru South Tejasvi Surya has found himself at the centre of a controversy after a woman broke her silence and accused him of abusing her for five years.

Amidst controversy over BJP’s decision to field this 28-year-old hardline Hindutva activist from the prestigious constituency, a businesswoman, Dr Som Dutta, took to Twitter to share some grisly details about him.

In a series of tweets, which are since inaccessible, Som Dutta accused the BJP candidate of being a 'womaniser, abuser and woman beater' and asked people if they wanted to 'blindly support him'. She also alleged she was not his first victim or would be the last and also claimed to be ready to share the proof.

Som Dutta said that she suffered for over five years before she made it stop by taking serious measures. She said that she was not his first victim, nor his last.

Dutta's tweets were shared by the Karnataka Congress, which asked if Tejasvi was another M J Akbar in the making and said that Bangalore South will remember the candidature.

However, after her tweets went viral, Dutta deleted them and put up a tweet asking people to leave the issue alone, as they are both from good families and people will get hurt if the matter is dragged further. At this time, her Twitter profile appears to be inactive.

Comments

Arch. Razak
 - 
Monday, 20 Apr 2020

His forefathers in India use to impose Breast Tax (Mulakkaram or mula-karam in Malayalam) was a tax imposed on the lower caste and untouchable Hindu women by the Kingdom of Tranvancore (in present-day Kerala state of India) if they wanted to cover their breasts in public, until 1924. Secondly he continuously molested and sexually tortured female named Som Dutta for 5 years and she broke her silence recently in social media. Now this "molester" without any knowledge barking in public about Arab women.

kumar
 - 
Thursday, 28 Mar 2019

This is not strange.  This person is following the rules + regulations of sangh parivar.    Abusing, beating, raping, molesting, mob lynching, attacking innocents, burning their property etc are their  culture and way of life.  

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 5,2020

Tightening control over companies misleading advertisements of medicines and products, the Indian government could soon slap a fine of up to Rs10 lakh and up to two years' imprisonment. While repeat offender could be fined up to Rs50 and imprisonment up to five years.

The Ministry of Health and Family Welfare's new draft of the Drugs and Magic Remedies (Objectionable Advertisements) (Amendment) Bill, 2020, provides extremely stringent penalties compared to the current law.

Under the new Act, companies advertising medicines and products falsely claiming to make a person fairer, improve height and memory or cure issues like hair loss or greying and premature ageing, among several others, may attract more stringent fines and jail time.

The current Act, 1954, leaves scope for companies to create deceptive advertisements as first time offender can be jailed for six months while repeat offender can be up to one year in prison, reported The Indian Express.

Under the Bill, deceptive advertisements will cover digital advertising, notice, circular, label, wrapper, invoice, banner and poster, among others. The government also plans to expand the scope of the law under the proposed amendments to cover 24 more deceptive claims not included in the current law, like medicines that can cure AIDS, change the sex of a foetus, among others, reported Livemint.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 22,2020

Mangaluru, Jul 22: On the direction of the Karnataka government, private medical colleges in Dakshina Kannada have reserved 4,000 beds for the treatment of Covid-19 infected patients.

With this, the district will have a total of 4,720 beds for the treatment including that from the government set up.

The district administration has directed the eight private medical colleges to reserve 50 of its beds for treating the infected patients. Accepting the direction of the district administration, the management of medical colleges have submitted details on the beds reserved to the authorities concerned.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 22,2020

Mangaluru, May 22: Dakshina Kannada today reported a fresh case of coronavirus infection, taking the coastal district's tally to 62. 

The new patient is a 29-year-old womon, who was under instituional quarantine monitored by the district administration in Belthangady. 

She had returned from Mumbai on May 18. Her throat swabs were sent for covid-19 testing on the following day and today she received positive result.

Out of the 62 covid-19 cases detected in Dakshina Kannada so far, only 50 are residents of the district. Among 12 others 4 are from Kasaragod and 3 from Karkala, 2 each from Uttara Kannada and Mumbai, and 1 from Kalaburgi.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.